346 related articles for article (PubMed ID: 26526617)
1. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.
Pai P; Rachagani S; Lakshmanan I; Macha MA; Sheinin Y; Smith LM; Ponnusamy MP; Batra SK
Mol Oncol; 2016 Feb; 10(2):224-39. PubMed ID: 26526617
[TBL] [Abstract][Full Text] [Related]
2. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.
Zhi X; Tao J; Xie K; Zhu Y; Li Z; Tang J; Wang W; Xu H; Zhang J; Xu Z
Cancer Lett; 2014 Apr; 346(1):104-13. PubMed ID: 24374017
[TBL] [Abstract][Full Text] [Related]
3. MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer.
Pai P; Rachagani S; Dhawan P; Sheinin YM; Macha MA; Qazi AK; Chugh S; Ponnusamy MP; Mallya K; Pothuraju R; Batra SK
Genes Cancer; 2016 May; 7(5-6):154-168. PubMed ID: 27551331
[TBL] [Abstract][Full Text] [Related]
4. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation.
Momi N; Ponnusamy MP; Kaur S; Rachagani S; Kunigal SS; Chellappan S; Ouellette MM; Batra SK
Oncogene; 2013 Mar; 32(11):1384-95. PubMed ID: 22614008
[TBL] [Abstract][Full Text] [Related]
5. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
6. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1.
Rachagani S; Macha MA; Ponnusamy MP; Haridas D; Kaur S; Jain M; Batra SK
Carcinogenesis; 2012 Oct; 33(10):1953-64. PubMed ID: 22791819
[TBL] [Abstract][Full Text] [Related]
7. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
Seshacharyulu P; Ponnusamy MP; Rachagani S; Lakshmanan I; Haridas D; Yan Y; Ganti AK; Batra SK
Oncotarget; 2015 Mar; 6(7):5164-81. PubMed ID: 25686822
[TBL] [Abstract][Full Text] [Related]
8. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
9. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
Kumar S; Das S; Rachagani S; Kaur S; Joshi S; Johansson SL; Ponnusamy MP; Jain M; Batra SK
Oncogene; 2015 Sep; 34(37):4879-89. PubMed ID: 25531332
[TBL] [Abstract][Full Text] [Related]
10. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.
Torres MP; Ponnusamy MP; Chakraborty S; Smith LM; Das S; Arafat HA; Batra SK
Mol Cancer Ther; 2010 May; 9(5):1419-31. PubMed ID: 20423995
[TBL] [Abstract][Full Text] [Related]
11. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies.
Mimeault M; Johansson SL; Senapati S; Momi N; Chakraborty S; Batra SK
Cancer Lett; 2010 Sep; 295(1):69-84. PubMed ID: 20303649
[TBL] [Abstract][Full Text] [Related]
12. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.
Zhang JJ; Zhu Y; Xie KL; Peng YP; Tao JQ; Tang J; Li Z; Xu ZK; Dai CC; Qian ZY; Jiang KR; Wu JL; Gao WT; Du Q; Miao Y
Mol Cancer; 2014 May; 13():130. PubMed ID: 24884523
[TBL] [Abstract][Full Text] [Related]
13. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
14. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
[TBL] [Abstract][Full Text] [Related]
15. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
[TBL] [Abstract][Full Text] [Related]
16. Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure.
Hou N; Ye B; Li X; Margulies KB; Xu H; Wang X; Li F
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301468
[TBL] [Abstract][Full Text] [Related]
17. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin-TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation.
Danek P; Kardosova M; Janeckova L; Karkoulia E; Vanickova K; Fabisik M; Lozano-Asencio C; Benoukraf T; Tirado-Magallanes R; Zhou Q; Burocziova M; Rahmatova S; Pytlik R; Brdicka T; Tenen DG; Korinek V; Alberich-Jorda M
Blood; 2020 Nov; 136(22):2574-2587. PubMed ID: 32822472
[TBL] [Abstract][Full Text] [Related]
19. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
20. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.
Macha MA; Rachagani S; Gupta S; Pai P; Ponnusamy MP; Batra SK; Jain M
Cancer Lett; 2013 Dec; 341(2):166-77. PubMed ID: 23920124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
